威斯康星州 的 急性髓系白血病 临床试验
威斯康星州 有 25 项针对 急性髓系白血病 的研究正在招募参与者。
威斯康星州 的城市
官方研究文本（英文）
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Gundersen Lutheran Medical Center, La Crosse
招募中2 期
60 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07437950Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- 以及另外 6 项
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月28日 · NCT05554393MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- 以及另外 41 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT05564390Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- Duluth Clinic Ashland, Ashland
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
- 以及另外 9 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06672146Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- 以及另外 11 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- 以及另外 8 项
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月22日 · NCT05554406A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- 以及另外 1 项
招募中3 期
6 Months – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT04293562A Study of BGB-11417 in Participants With Myeloid Malignancies
- Medical College of Wisconsin, Milwaukee
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT04771130Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
招募中3 期
1 至 25 岁 · 所有性别 · 更新于 2026年9月4日 · NCT07022678Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 以及另外 46 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
招募中1/2 期
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Froedtert & Medical College Clinics, Milwaukee
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Wisconsin, Madison
- Froedtert & Medical College of Wisconsin, Milwaukee
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT07007312ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Medical College of Wisconsin, Milwaukee
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月18日 · NCT06656494A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Wisconsin - Madison, Madison
- Children's Hospital of Wisconsin, Milwaukee
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2026年7月6日 · NCT01351545Ivosidenib as Post-HSCT Maintenance for AML
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年6月18日 · NCT06707493Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Wisconsin, Milwaukee
招募中观察性研究
0 至 38 岁 · 所有性别 · 更新于 2026年6月4日 · NCT06131801SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
- University of Wisconsin Carbone Cancer Center, Madison
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年5月14日 · NCT06222580A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Froedtert & Medical College of Wisconsin, Milwaukee
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年4月30日 · NCT04256317Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
- University of Wisconsin Carbone Cancer Center, Madison
招募中1 期
21 岁及以下 · 所有性别 · 更新于 2026年4月22日 · NCT05101551A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Wisconsin Hospital and Clinics, Madison
- Medical College of Wisconsin Cancer Center, Milwaukee
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年3月13日 · NCT05735184Venetoclax to Augment Epigenetic Modification and Chemotherapy
- Children's Wisconsin, Milwaukee
招募中1 期
1 至 25 岁 · 所有性别 · 更新于 2026年1月12日 · NCT05317403Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- University of Wisconsin Carbone Cancer Center, Madison
招募中1 期
7 Months – 21 Years · 所有性别 · 更新于 2025年10月16日 · NCT02508038A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- University of Wisconsin Clinical Science Center, Madison
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2025年9月24日 · NCT06501196Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- University of Wisconsin, Madison
招募中欢迎健康志愿者
18 至 120 岁 · 所有性别 · 更新于 2025年7月25日 · NCT05237258数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。